Tag: licensing
-
Biotech Start-Up Gains $90M for Neurodegenerative Diseases
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds.
-
New Company Forms to Ease Scientific Data Operations
A new company spun off from Harvard University aims to simplify data analysis, management, and collaboration for life science researchers.
-
Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases.
-
Pharma, Biotech Partner on Off-the-Shelf Cell Therapies
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells.
-
Fine-Tuning Process Devised for Gene Therapies
Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases.
-
3-D Printed Scaffold Helps Regrow Soft Tissue
Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth.
-
GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal
GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders.
-
Microbiome Drug Candidate Licensed in $525M Deal
A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science.
-
Long-Acting Capsule Helps Reduce Opioid Use
A capsule designed to take once a week is shown in animal tests to continuously deliver a craving-reduction drug in that time and suppress opioid intake.
-
Plant-Based Material Designed to Replace Plastics
Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics.